Cyfra 21-1 – Tumor Marker Analysis
550,00 د.إThe Cyfra 21-1 test is a specialized tumor marker analysis. It measures the levels of Cytokeratin 19 fragments in your blood serum.
Sample Type : Serum
Methodology : TBA
TAT : 10 Days
Showing all 3 results

The Cyfra 21-1 test is a specialized tumor marker analysis. It measures the levels of Cytokeratin 19 fragments in your blood serum.
Sample Type : Serum
Methodology : TBA
TAT : 10 Days

Tumor Markers Screen (Female) is a powerful, non-invasive blood test that measures five critical tumor markers: CEA, CA 15.3, CA 19.9, CA 125, and AFP.
Sample Type : Serum
Methodology : Chemiluminescence
TAT : 1 Day

Tumor Markers Screen (Male) is a comprehensive 6-parameter surveillance system. By analyzing specific biomarkers in your blood, CA 19.9, CEA, PSA-Total, PSA-Free, AFP, and BhCG, this panel offers a panoramic view of your cancer risk.
Sample Type : Serum
Methodology : Chemiluminescence
TAT : 1 Day